Blastocystis infectious disease

Summary

Blastocystis infectious disease (MONDO:0005671) is a disease and 3 clinical trials. A subtype of amebiasis — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

At a glance

• Clinical trials: 3

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	Blastocystis infectious disease
Mondo ID	MONDO:0005671
EFO	EFO:0007173
MeSH	D016776
SNOMED CT	721809007
Is cancer (heuristic)	no

Also known as: Blastocystis infection · infection, Blastocystis · infections, Blastocystis

Disease family

This is a subtype of amebiasis. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › parasitic infectious disease › protozoa infectious disease › amebiasis › Blastocystis infectious disease

Related subtypes (1): amebic dysentery

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 3.

Phase distribution (across all retrieved trials)

Phase	Trials
Not specified	3

Top trials by phase / activity

NCT	Phase	Status	Title
NCT05580393	Not specified	UNKNOWN	Molecular Characterization of Blastocystis Isolates From Human by Restriction Fragment Length Polymorphism (RFLP) Analysis
NCT05724368	Not specified	UNKNOWN	Efficacy of Calprotectin as A Marker For the Pathogenicity of Blastocystis Infection
NCT06379035	Not specified	UNKNOWN	Blastocystis and Cryptosporidium Infection in Colorectal Cancer Patients